CuraTeQ Biologics receives approval for Biosimilar Zefylti from the UK’s MHRA CuraTeQ Biologics receives approval for Biosimilar Zefylti from the UK’s MHRA The company has a market cap of over Rs 70,000 crore and the stock is up by 24.3 per cent from its 52-week low of Rs 994.35 per share. DSIJ Intelligence-1 / Wednesday, May 14, 2025 0 104 Article rating: 5.0 The company has a market cap of over Rs 70,000 crore and the stock is up by 24.3 per cent from its 52-week low of Rs 994.35 per share. Read more
Pharma penny stock under Rs 40 bags new order worth USD 1,38,075 from Taha Drugs & Chemicals Co. Ltd Pharma penny stock under Rs 40 bags new order worth USD 1,38,075 from Taha Drugs & Chemicals Co. Ltd The stock is up 11.15 per cent from its 52-week low of Rs 35.70 per share.. DSIJ Intelligence-1 / Monday, May 5, 2025 0 265 Article rating: 4.3 The stock is up 11.15 per cent from its 52-week low of Rs 35.70 per share. Read more
Pharma company receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg & tentative approval for other strengths of Rivaroxaban Tablets USP Pharma company receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg & tentative approval for other strengths of Rivaroxaban Tablets USP Aurobindo Pharma Limited announced obtaining the last approval from the US Food & Drug Administration (USFDA) for Rivaroxaban Tablets USP, 2.5 mg. DSIJ Intelligence-1 / Monday, April 14, 2025 0 211 Article rating: 5.0 The biosimilars division alongside niche product development represents Aurobindo Pharma's main focus areas where its 1500 scientists dedicate their efforts. Read more
Pharma Company Enters Into Share Purchase Agreement and Power Supply Agreement with Torrent Urja 19 Pvt Ltd Pharma Company Enters Into Share Purchase Agreement and Power Supply Agreement with Torrent Urja 19 Pvt Ltd The company has a market cap of over Rs 13,000 crore and the stock is up 45 per cent from its 52-week low of Rs 743.60 per share. DSIJ Intelligence-1 / Thursday, April 3, 2025 0 236 Article rating: 4.5 The company has a market cap of over Rs 13,000 crore and the stock is up 45 per cent from its 52-week low of Rs 743.60 per share. Read more
46 Per Cent Returns From 52-Week Low: Pharma Stock Under Rs 75, Hit 10 Per Cent Upper Circuit; Here’s Why 46 Per Cent Returns From 52-Week Low: Pharma Stock Under Rs 75, Hit 10 Per Cent Upper Circuit; Here’s Why The company has a market cap of over Rs 400 crore and the stock is up by 46 per cent from its 52-week low of Rs 50.42 per share. DSIJ Intelligence-1 / Thursday, April 3, 2025 0 193 Article rating: 5.0 The company has a market cap of over Rs 400 crore and the stock is up by 46 per cent from its 52-week low of Rs 50.42 per share. Read more